Amgen Inc. is reported as the largest shareholder of Neumora Therapeutics, Inc.
1 report, 0 independent
Updated Jul 2
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Amgen Inc. is reported as the largest shareholder of Neumora Therapeutics, Inc.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amgen
American multinational biopharmaceutical company
-
Neumora Therapeutics, Inc.
biopharmaceutical company
Nothing else this week.
Related events
- Amgen Inc. trades on the NASDAQ stock exchange.
- Royalty Pharma acquired a royalty interest in Amgen's drug Imdelltra.
- Reports on the top holdings of various healthcare and biotech ETFs, listing major pharmaceutical companies like Eli Lilly, Amgen, and Johnson & Johnson.
- Amgen and Merck are currently competing against each other in the market for investor capital.
- Joint drug trial success boosts Amgen stock.
Coverage
Newest first; wire copies grouped- Unknown outlet